Pharmacotherapy of scleritis: Current paradigms and future directions

Keyphrases

• Pharmacotherapy 100%
• Scleritis 100%
• Emerging Therapies 33%
• Biological Response Modifiers 33%
• Clinical Trials 16%
• Non-steroidal Anti-inflammatory Drugs (NSAIDs) 16%
• Mechanism of Action 16%
• Therapeutic Potential 16%
• Inappropriate Use 16%
• Immunomodulator 16%
• MEDLINE 16%
• Traditional Therapy 16%
• Potential Adverse Effects 16%
• Expert Opinion 16%
• Drug Candidates 16%
• Non-infectious 16%
• Antimetabolites 16%
• Inflammatory Conditions 16%
• Treatment Drugs 16%
• Subject Headings 16%
• Relative Contraindications 16%
• Oral Corticosteroids 16%
• Local Drug Delivery 16%
• Potential Drugs 16%
• Refractory Cases 16%
• T Cell Inhibitors 16%
• Inhibitor Response 16%
• Area Cover 16%
• Treatment Modalities 16%
• Novel Treatments 16%
• Systemic Inflammatory Diseases 16%

Medicine and Dentistry

• Drug Therapy 100%
• Scleritis 100%
• Biological Response Modifier 33%
• T Cell 16%
• Clinical Trial 16%
• Serositis 16%
• Adverse Event 16%
• Inflammatory Disorder 16%
• Nonsteroid Antiinflammatory Agent 16%
• Immunomodulating Agent 16%
• Antimetabolite 16%
• Contraindication 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Pharmacotherapy 100%
• Scleritis 100%
• Biological Response Modifier 33%
• Clinical Trial 16%
• Non-Steroidal Anti-Inflammatory Drug 16%
• Inflammatory Disease 16%
• Adverse Event 16%
• Immunomodulating Agent 16%
• Inflammation 16%
• Antimetabolite 16%